Source: International Congress 2019 – Sarcoidosis: a multifaceted disease that is difficult to manage
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
U. Zinchenko (St. Petersburg, Russian Federation), A. Starshinova (St. Petersburg, Russian Federation), N. Basantsova (St. Petersburg, Russian Federation), A. Malkova (St. Petersburg, Russian Federation), E. Surkova (St. Petersburg, Russian Federation), S. Lapin (St. Petersburg, Russian Federation), B. Gildburd (St. Petersburg; Tel Hashomer, Israel), L. Churilov (St. Petersburg, Russian Federation), P. Yablonskiy (St. Petersburg, Russian Federation). Detection of various autoantibodies in patients with pulmonary sarcoidosis. 1380

Member's Comments

No comment yet.

Related content which might interest you: Autoantibodies in patients with idiopathic pulmonary fibrosis Source: International Congress 2019 – Interstitial lung disease registries Year: 2019 Evaluation of specific immune complexes in patients with pulmonary sarcoidosis. Source: International Congress 2018 – Granulomatous disorders: heterogeneous diseases with variable management Year: 2018 The comparison of the manifestation of systemic inflammation in patients with minor forms of tuberculosis and pulmonary sarcoidosis Source: Annual Congress 2009 - Clinical tuberculosis Year: 2009 Clinical implications of ANCA positivity in idiopathic pulmonary fibrosis patients Source: Breathe, 16 (1) 190321; 10.1183/20734735.0321-2019 Year: 2020 Incidence, clinical manifestations and prognosis of cardiac sarcoidosis in patients with pulmonary sarcoidosis Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013 Vascular dysfunction in patients with pulmonary sarcoidosis Source: Annual Congress 2007 - Sarcoidosis: various aspects Year: 2007 The study of pulmonary circulation in the patients with pulmonary sarcoidosis Source: Eur Respir J 2001; 18: Suppl. 33, 415s Year: 2001 Charactaristics and prognosis of autoimmune antibody-positive patients of idiopathic pulmonary arterial hypertension Source: Virtual Congress 2021 – Pulmonary hypertension in the COVID-19 pandemic and beyond Year: 2021 Significance of abnormal autoantibodies in patients presenting with IPF Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis Year: 2012 Clinical significance of autoantibody screening in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Diffuse pulmonary fibrosis Year: 2013 Prognosis of pulmonary sarcoidosis in young patients Source: Eur Respir J 2003; 22: Suppl. 45, 45s Year: 2003 Relationship between MIF and cellular pattern in BAL of patients with sarcoidosis, systemic sclerosis, idiopathic pulmonary fibrosis Source: Eur Respir J 2003; 22: Suppl. 45, 377s Year: 2003 Characteristics of pulmonary cavitary lesions in patients with pulmonary TB Source: Eur Respir J 2004; 24: Suppl. 48, 199s Year: 2004 Characteristics of pulmonary cavitary lesions in patients with pulmonary TB Source: Eur Respir J 2003; 22: Suppl. 45, 247s Year: 2003 Characteristics of pulmonary cavitary lesions in patients with pulmonary TB Source: Eur Respir J 2006; 28: Suppl. 50, 28s Year: 2006 How to recognise and what to do about pulmonary sarcoidosis Source: International Congress 2019 – State of the art session: Interstitial lung diseases Year: 2019 Renal involvement in chronic pulmonary sarcoidosis Source: Eur Respir J 2005; 26: Suppl. 49, 550s Year: 2005 Variants of the clinical course of familial pulmonary sarcoidosis Source: International Congress 2019 – Sarcoidosis: a multifaceted disease that is difficult to manage Year: 2019 Change in pulmonary function among patients with bronchiectasis with or without non-tuberculous mycobacterial pulmonary disease Source: International Congress 2019 – Complex respiratory infections in clinical practice Year: 2019 Pathogenesis of pulmonary fibrosis in sarcoidosis Source: Virtual Congress 2020 – Severe thoracic sarcoidosis : where do we stand ? Year: 2020